Drug – bio-affecting and body treating compositions – Malaria
Reexamination Certificate
2004-09-20
2010-12-14
Arnold, Ernst V (Department: 1616)
Drug, bio-affecting and body treating compositions
Malaria
C424S464000, C514S313000, C514S452000
Reexamination Certificate
active
07851512
ABSTRACT:
The present invention provides a novel combination comprising artemisinin in the form of tablets and related dosage forms for pediatric use, such as granules, suppository, suspension syrup and dry powder, for the treatment of human malarias including multiple-resistant subtertian malaria, tertian malaria and quartan malaria. The combination is comprised of artemisinin, piperaquine and primaquine. Clinical tests in Southeast Asia countries where malaria is epidemic demonstrate that, apart from having high and rapid therapeutic effect possessed by the most excellent domestic and foreign artemisinin-type anti-malarial drugs, the present combination is also featured with shorter course of treatment, less side effect, lower material cost, and more convenience for administration, and its ability of rapidly killing gametophyte and cutting off infection source thereby blocking spreading of malaria is a further improvement.
REFERENCES:
patent: 5219865 (1993-06-01), Chatterjee et al.
patent: 5270037 (1993-12-01), Bienzle
patent: 7670631 (2010-03-01), Mota et al.
patent: 2004/0058981 (2004-03-01), Lai et al.
patent: 1237416 (1999-12-01), None
patent: 1305810 (2001-08-01), None
patent: 0290959 (1988-11-01), None
patent: WO-96/40108 (1996-12-01), None
patent: WO-02/26226 (2002-04-01), None
Giao et al. [online] retrieved from the internet on Dec. 12, 2008: http://resource.actmalaria.net/v1/index.php?m=resource&db=biblio&entry—id=1276&submit—user=Details&search—term=aminoquinoline&search—title=&search—type=&search—author=&search—country=&search—publisher=&search—language=&search—subject=&search—isbn=&search—pubyear=; Dec. 2002; 2 pages.
White (Phil Trans R Soc Lond B 1999, 354, 739-749).
Klayman (Science 1985, 228(4703), 1049-1055).
Denis, M.B. et al., “Efficacy and Safety of Dihydroartemisinin-Piperaquine (Artekin) in Cambodian Children and Adults with Uncomplicated Falciparum Malaria.”Clin. Inf. Dis. 35(12), 1469-1476 (2002).
Huang, J.R. et al., “A study of artemether combined with primaquine in the treatment of falciparum malaria.”Database Medline(Online), U.S. National Library of Medicine, Bethesda, MD, US, 2001, Database Accession No. NLM12572052 (abstract only).
Chawira, N. et al., “The effect of artemisinin combined with standard antimalarials against chloroquine-sensitive and chloroquine-resistant strains ofPlasmodium falciparum in vitro.” Journal of Tropical Medicine and Hygiene90, 1-8 (1987).
Giao, P.T. et al., “CV8, a new combination of dihydroartemisinin, piperaquien, trimethoprim and primaquine, compared with atovaquone-proguanil against falcipraum malaria in Vietnam.”Tropical Medicine and International Health9(1), 109-116 (2004).
“Antimalarial Drug Combination Therapy: Report of a WHO Technical Consultation.” World Health Organization, 2001, 1-30.
Jaeger, A. et al., “Clinical features and management of poisoning due to antimalarial drugs.”Med. Toxicol. Adverse Drug Exp. Jul.-Aug. 1987; 2(4): 242-73.
Srivastava, P. et al., “Glutathione S transferase activity in malarial parasites.”Tropical Medicine and International Health4(4), Jan. 5, 2002, 251-254.
Song, J. et al., “Clinical Observation of Dihydroartemisinin and Piperaquine in Treating Falciparum Malaria without Complication.”National Medical Journal of China83(12), Jun. 25, 2003, 1099-1100 (original article plus English translation).
Guogiao Li
Song Jianping
Arnold Ernst V
Connolly Bove & Lodge & Hutz LLP
LandOfFree
Composition containing artemisinin for treatment of malaria does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Composition containing artemisinin for treatment of malaria, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Composition containing artemisinin for treatment of malaria will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4153439